SE8900752L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8900752L
SE8900752L SE8900752A SE8900752A SE8900752L SE 8900752 L SE8900752 L SE 8900752L SE 8900752 A SE8900752 A SE 8900752A SE 8900752 A SE8900752 A SE 8900752A SE 8900752 L SE8900752 L SE 8900752L
Authority
SE
Sweden
Prior art keywords
inflammatory
steroidal anti
acid
pharmaceutical composition
meferamic
Prior art date
Application number
SE8900752A
Other languages
English (en)
Swedish (sv)
Other versions
SE8900752D0 (sv
Inventor
R Stables
Original Assignee
R Stables
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Stables filed Critical R Stables
Publication of SE8900752D0 publication Critical patent/SE8900752D0/xx
Publication of SE8900752L publication Critical patent/SE8900752L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SE8900752A 1988-03-04 1989-03-03 Farmaceutisk komposition SE8900752L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805268A GB8805268D0 (en) 1988-03-04 1988-03-04 Medicaments

Publications (2)

Publication Number Publication Date
SE8900752D0 SE8900752D0 (sv) 1989-03-03
SE8900752L true SE8900752L (sv) 1989-09-05

Family

ID=10632893

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900752A SE8900752L (sv) 1988-03-04 1989-03-03 Farmaceutisk komposition

Country Status (12)

Country Link
JP (1) JP2834175B2 (da)
KR (1) KR890014110A (da)
AU (1) AU3098489A (da)
BE (1) BE1002256A3 (da)
DE (1) DE3906884A1 (da)
DK (1) DK104489A (da)
FR (1) FR2627985A1 (da)
GB (2) GB8805268D0 (da)
IT (1) IT8947714A0 (da)
NL (1) NL8900525A (da)
SE (1) SE8900752L (da)
ZA (1) ZA891640B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300260B1 (no) 1993-05-05 1997-05-05 Torgersen Hans & Soenn Bilbarnestol
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
JP2003510263A (ja) * 1999-09-24 2003-03-18 アルコン，インコーポレイテッド シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655104A5 (fr) * 1980-02-28 1986-03-27 Glaxo Group Ltd Derives heterocycliques triazoliques, procedes pour leur preparation et compositions pharmaceutiques les comportant.
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
DK104489A (da) 1989-09-05
ZA891640B (en) 1990-03-28
GB8904879D0 (en) 1989-04-12
FR2627985A1 (fr) 1989-09-08
GB8805268D0 (en) 1988-04-07
DE3906884A1 (de) 1989-09-14
BE1002256A3 (fr) 1990-11-06
AU3098489A (en) 1989-09-07
GB2216413A (en) 1989-10-11
JPH01316319A (ja) 1989-12-21
SE8900752D0 (sv) 1989-03-03
DK104489D0 (da) 1989-03-03
KR890014110A (ko) 1989-10-21
JP2834175B2 (ja) 1998-12-09
NL8900525A (nl) 1989-10-02
IT8947714A0 (it) 1989-03-03

Similar Documents

Publication Publication Date Title
IE873427L (en) Pharmaceutical delivery systems
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
ITMI942484A0 (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
AU7534087A (en) Sustained release pharmaceutical compositions in oral dosage form
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
EE03137B1 (et) Veterinaarravim ja protsess selle valmistamiseks
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
EP1246608A4 (en) PHARMACEUTICAL FORMULATIONS FOR THE ADMINISTRATION OF MEDICAMENTS HAVING A LOW AQUEOUS SOLUBILITY
DE69109557D1 (de) Überzogene feste Arzneiform mit Verabreichungsmöglichkeit im Dickdarm.
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
KR930009605A (ko) 소염 또는 진통제
ATE173923T1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
SE8900752L (sv) Farmaceutisk komposition
SE8803822D0 (sv) Novel dosage form
DE69710423D1 (de) Orale pharmazeutische Zubereitung mit antipyretischer, analgetischer und entzündungshemmender Wirkung.
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
JPH1135456A5 (da)
SE8902458D0 (sv) Laekemedelskomposition
PT1216035E (pt) Preparacao que contem ingredientes activos e/ou agentes auxiliares com uma libertacao controlada destas substancias e a utilizacao e producao das mesmas
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
BR9608271A (pt) Dispositivo para misturar uma composição farmaceutica preferivelmente seca e granulada com um agente preferivelmente fluido para formar uma preparação preferivelmente um gel ou similar e processos para preparar uma preparação farmacêutica e para administrar a mesma a um ser vivo

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8900752-0

Effective date: 19901227

Format of ref document f/p: F